Avanos Medical, Inc. (AVNS)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-QLatest | Q1-2026 | 8-K (2026-05-05) · 99.1 | ||
| 10-KLatest | FY-2025 | 8-K (2026-02-24) · 99.1 | ||
| 10-Q | Q3-2025 | 8-K (2025-11-05) · 99.1 | ||
| 10-Q | Q2-2025 | 8-K (2025-08-05) · 99.1 · 99.2 · 99.3 | ||
| 10-Q | Q1-2025 | 8-K (2025-05-06) · 99.1 | ||
| 10-K | FY-2024 | 8-K (2025-02-26) · 99.1 | ||
| 10-Q | Q3-2024 | 8-K (2024-10-30) · 99.1 | ||
| 10-Q | Q2-2024 | 8-K (2024-07-31) · 99.1 | ||
| 10-Q | Q1-2024 | 8-K (2024-05-02) · 99.1 | ||
| 10-K | FY-2023 | 8-K (2024-02-20) · 99.1 | 8-K (2024-01-04) · 99.1 | ||
| 10-Q | Q3-2023 | 8-K (2023-11-01) · 99.1 | ||
| 10-Q | Q2-2023 | 8-K (2023-08-09) · 99.1 · 99.2 |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Cover Page | ||
| Audit Information | — |
|
| Statements | ||
| Consolidated Income Statements | ||
| Condensed Consolidated Statements of Comprehensive (loss) Income | — |
|
| Consolidated Income (loss) Statements | — |
|
| Consolidated Balance Sheets | ||
| Consolidated Statements of Comprehensive Income (loss) | ||
| Consolidated Balance Sheets (P) | ||
| Consolidated Statement of Stockholders Equity | ||
| Consolidated Cash Flow Statements | ||
| Notes | ||
| Accounting Policies | ||
| Accumulated Other Comprehensive Income | ||
| Accumulated Other Comprehensive Loss | — |
|
| Business Acquisitions | ||
| Business and Products Information | ||
| Commitments and Contingencies | ||
| Cybersecurity Risk Management and Strategy Disclosure | — |
|
| Debt | ||
| Derivative Financial Instruments | ||
| Discontinued Operations | ||
| Earnings Per Share ("eps") | ||
| Employee Benefit Plans | — |
|
| Fair Value Information | ||
| Goodwill | — |
|
| Goodwill and Intangibles Impairment | — |
|
| Goodwill Impairment | — |
|
| Income Taxes | — |
|
| Insider Trading Arrangements | ||
| Insider Trading Policies and Procedures | — |
|
| Leases | — |
|
| Pay Vs Performance Disclosure | ||
| Restructuring | — |
|
| Restructuring Activities | — |
|
| Revenue | ||
| Segment Information | ||
| Share Repurchase Program | ||
| Stock-based Compensation | ||
| Subsequent Event | — |
|
| Supplemental Balance Sheet Information | ||